While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Delays in diagnosing and treating psoriatic arthritis—a common inflammatory disorder affecting around 200,000 people in the U ...

Delays in diagnosing and treating psoriatic arthritis – a common inflammatory disorder affecting 112 in every 100,000 adults – are causing irreparable ...

The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

Psoriatic arthritis can affect any joint in the body ... % of people with PsA have at least one close family member who has psoriasis or PsA. Additionally, researchers have been able to identify ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

Korea: A recent retrospective cohort study published in the Journal of the American Academy of Dermatology explored the link ...

Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...

Germany: A team of researchers from Germany developed a deep learning model using a convolutional neural network (CNN) to ...